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Abstract
Background: Trypanosoma cruzi is the etiological agent of Chagas’ disease. During the parasite life cycle, many molecules
are involved in the differentiation process and infectivity. Peptidases are relevant for crucial steps of T. cruzi life cycle; as
such, it is conceivable that they may participate in the metacyclogenesis and interaction with the invertebrate host.
Methodology/Principal Findings: In this paper, we have investigated the effect of the calpain inhibitor MDL28170 on the
attachment of T. cruzi epimastigotes to the luminal midgut surface of Rhodnius prolixus, as well as on the metacyclogenesis
process and ultrastructure. MDL28170 treatment was capable of significantly reducing the number of bound epimastigotes
to the luminal surface midgut of the insect. Once the cross-reactivity of the anti-Dm-calpain was assessed, it was possible to
block calpain molecules by the antibody, leading to a significant reduction in the capacity of adhesion to the insect guts by
T. cruzi. However, the antibodies were unable to interfere in metacyclogenesis, which was impaired by the calpain inhibitor
presenting a significant reduction in the number of metacyclic trypomastigotes. The calpain inhibitor also promoted a direct
effect against bloodstream trypomastigotes. Ultrastructural analysis of epimastigotes treated with the calpain inhibitor
revealed disorganization in the reservosomes, Golgi and plasma membrane disruption.
Conclusions/Significance: The presence of calpain and calpain-like molecules in a wide range of organisms suggests that
these proteins could be necessary for basic cellular functions. Herein, we demonstrated the effects of MDL28170 in crucial
steps of the T. cruzi life cycle, such as attachment to the insect midgut and metacyclogenesis, as well as in parasite viability
and morphology. Together with our previous findings, these results help to shed some light on the functions of T. cruzi
calpains. Considering the potential roles of these molecules on the interaction with both invertebrate and vertebrate hosts,
it is interesting to improve knowledge on these molecules in T. cruzi.
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Introduction
Chagas’ disease is a neglected tropical disease, which remains
a major health problem in Latin America. Over eight million
people are infected with this disease and an estimated of 14,000
people die as a consequence of the infection every year [1]. The
etiological agent Trypanosoma cruzi undergoes profound morpho-
logical changes during its development in a complex life cycle
involving mammalian and invertebrate hosts. The protozoa life
cycle comprises three major morphological stages: epimasti-
gotes, trypomastigotes, and amastigotes [2]. During the
infection of the invertebrate host, a hemipteran insect of the
Reduviidae order, non-infectious epimastigotes adhere to the
insect host midgut, begin to proliferate and differentiate
(metacyclogenesis process) into metacyclic trypomastigotes,
which are non-proliferative forms that are able to infect a
mammalian host [3]. The adhesion to the luminal midgut
surface of the insect appears to be necessary for the
metacyclogenesis, but there is a general lack of information
about which molecules are implicated in this process [3,4]. In
this context, peptidases, a class of hydrolytic enzymes respon-
sible for breaking peptide bonds, has attracted the attention of
our research group because of their role in several crucial steps
o ft h el i f ec y c l eo ft h et r y p a n o s o m a t i dp a r a s i t e s[ 5 ] .A m o n gT.
cruzi different peptidases that we considered, the calpains have
been presenting interesting findings and seem to be a
remarkable target for the development of an alternative target
to treat Chagas’ disease and leishmaniasis [6,7,8].
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cysteine peptidases that have been characterized mainly in
humans and whose role still remains poorly understood [9]. Some
evidence indicates that these enzymes may participate in a variety
of cellular processes, including the rearrangement of cytoskeletal
proteins, different signal transduction pathways and apoptosis. In
this context, a variety of calpain inhibitors are under development
and the potential clinical utility of these compounds have been
shown mainly in the treatment of neurodegenerative disorders
[10,11,12,13]. In this sense, a classical study employing whole
genome analyses showed the presence of a large and diverse family
of calpains in Trypanosoma brucei, Leishmania major and T. cruzi [14].
Some years before, the same group had already characterized a
trypanosomatid calpain-like protein in procyclic forms of T. brucei
[15]. In addition, our group described the presence of calpain-
related proteins in T. cruzi epimastigote forms and Leishmania
amazonensis promastigote forms and the effects of the calpain
inhibitor III (MDL28170) on growth, viability and infectivity
[6,7,8]. Calpain homologues were also described in the monoxenic
trypanosomatids Crithidia deanei and Herpetomonas samulpessoai
[16,17].
More studies are necessary to better understand the involve-
ment of the calpain homologues in the life cycle of T. cruzi. Here,
we have conducted a study to investigate the effect of the calpain
inhibitor MDL28170 on the attachment of T. cruzi epimastigotes
to the luminal midgut surface of Rhodnius prolixus, as well as on the
metacyclogenesis process and ultrastructure. In addition, we have
analyzed the effect of anti-calpain antibodies on the interaction of




The experiments were carried out in accordance with the
guidelines established by the FIOCRUZ Committee of Ethics for
the Use of Animals (CEUA L-028/09).
Chemicals
The calpain inhibitor III, MDL28170 (carbobenzoxy-valylphe-
nylalanial; Z-Val-Phe-CHO), was purchased from Calbiochem
(San Diego, CA, USA). Stock solutions of the drug (5 mM) were
prepared in dimethylsulfoxide (DMSO). All other reagents were
analytical grade or superior.
Parasite culture
Epimastigote forms of T. cruzi were grown in 3.7% brain heart
infusion medium (BHI), containing hemin and folic acid and
supplemented with 10% heat-inactivated fetal bovine serum, at
28uC for 4 days to reach late-log phase growth. For the following
experiments, epimastigotes were collected, washed three times in
0.15 M NaCl, 0.01 M phosphate-buffer pH 7.2 (PBS) and
immediately used. The Y strain of T. cruzi was used in all
experiments except for the metacyclogenesis assay, in which the
Dm28c strain is the best characterized model for in vitro
differentiation [18].
Insects
Rhodnius prolixus were reared and maintained as previously
described [19]. Briefly, fifth-instars larvae were starved for 30 days
after the last ecdysis and then allowed to feed on rabbit blood
through a membrane feeder. Ten days after the feeding, insects
were dissected; the posterior midguts were then removed,
longitudinally sectioned and washed three times in PBS to expose
their luminal surfaces. After the washing, the tissue fragments were
processed as described below. The insects were obtained from the
insectary of the Laborato ´rio Nacional e Internacional de
Refere ˆncia em Taxonomia de Triatomı ´neos, Instituto Oswaldo
Cruz, FIOCRUZ.
Identification of calpain homologues by flow cytometry
and fluorescence microscopy
Epimastigotes (1610
7 cells) from the Y strain used for these
experiments were fixed at 4uC in 0.4% paraformaldehyde in PBS
(pH 7.2) for 30 min, followed by extensive washing in the same
buffer. The fixed cells maintained their morphological integrity, as
verified by optical microscopic observation. After this step, the
cells were incubated for 1 h at room temperature with a 1:100
dilution of the anti-calpain antibodies. Cells were then incubated
for an additional hour with a 1:200 dilution of fluorescein
isothiocyanate (FITC)-labeled goat anti-rabbit IgG [20]. The cells
were then washed 3 times in PBS and observed in a Zeiss
epifluorescence microscope (Axioplan 2). Alternatively, the
parasite associated fluorescence was excited at 488 nm and
quantified on a flow cytometer (FACSCalibur, BD Bioscience,
USA) equipped with a 15 mW argon laser emitting at 488 nm.
Non-treated cells and those treated with the secondary antibody
alone were run in parallel as controls. Each experimental
population was then mapped by using a two-parameter histogram
of forward-angle light scatter versus side scatter. The mapped
population (n=10,000) was then analyzed for log green
fluorescence by using a single parameter histogram. The calpain
antibodies tested were: a rabbit antiserum raised against Drosophila
melanogaster calpain (anti-Dm-calpain) [21], anti-C21, anti-C23 or
anti-C24 raised against the whole molecule, the cysteine active site
and the histidine active site, respectively, of human brain m-
calpain [22], anti-CAP5.5, raised against the cytoskeleton-
associated protein from Trypanosoma brucei [15], and anti-CDPIIb
and anti-Ha-CalpM raised against Homarus americanus calpains
[23,24].
In vitro inhibition of T. cruzi-Rhodnius interaction
Live epimastigote forms (Y strain) were resuspended in 200 mlo f
fresh BHI to a density of 1610
7 cells and treated with the calpain
inhibitor for 1 h with sub-inhibitory concentrations (6.25–50 mM)
and washed in PBS. Under this experimental condition, the
parasite maintains their viability, as previously described [7].
Dilutions of DMSO corresponding to those used to prepare the
drug solution were assessed in parallel for control. Alternatively,
the parasites were incubated for 1 h with anti-calpain antibodies,
or rabbit pre-immune sera. After that, binding of protozoa to
insect gut was performed by a method similar to that described
previously [25]. Briefly, the parasites were incubated for 20 min at
28uC with R. prolixus dissected posterior midguts that were sliced
open longitudinally. Subsequently, the explanted midguts were
spread onto glass slides to count the number of attached parasites
per epithelial cells. The experiment was performed three times
independently, for each experimental group 4 insect midguts were
used and 100 epithelial cells were counted randomly.
In vitro inhibition of T. cruzi metacyclogenesis
For in vitro differentiation, epimastigotes (clone Dm28c) in the
stationary phase of growth were incubated for 2 h at 28uCi n
triatomine artificial urine (TAU) medium (190 mM NaCl, 17 mM
KCl, 2 mM MgCl2, 2 mM CaCl2, 8 mM phosphate buffer
pH 6.0) at a density of 5610
8 cells/ml. The parasites at a dilution
of 1:100 were further incubated for 96 h in TAU3AAG medium
MDL28170 Effects on T. cruzi
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glutamate, 2 mM L-sodium aspartate, and 10 mM D-glucose) in
culture flasks [18]. For inhibition assays, epimastigotes were
incubated in the presence, or absence (control), of increasing
concentrations of MDL28170 (6.25–50 mM) in TAU3AAG
medium or anti-calpain antibodies. Culture supernatants were
collected after 24, 48, 72, and 96 h of incubation in TAU3AAG
medium and the number of epimastigotes and metacyclic
trypomastigotes was determined by cell counting in a Neubauer
chamber. Under this experimental condition, the parasite
maintains their viability, as previously described [7]. These
morphological stages can be easily differentiated on morphological
grounds by light microscopy, since epimastigotes are broader and
have a quite rigid body, while trypomastigotes are slimmer and
present a vigorous wavy movement of the whole body. Three
independent experiments were performed in triplicate and a
DMSO dilution corresponding to highest drug concentration was
assessed in parallel.
Effects of MDL28170 on T. cruzi trypomastigotes viability
Bloodstream trypomastigote forms, obtained from infected
albino Swiss mice at the peak of parasitemia by differential
centrifugation, were resuspended in Dulbecco’s modified Eagle
medium supplemented with 10% fetal calf serum (DMEM). This
suspension was incubated at 37uC for 24 h in the presence of
increasing concentrations of MDL28170 (6.25–50 mM). Viability
was assessed by mobility of the parasite flagellum and lack of
staining after challenge with trypan blue. Dilutions of DMSO
corresponding to those used to prepare the drug solutions were
assessed in parallel. Thereafter, the number of viable motile
trypomastigotes was quantified by counting the flagellates in a
Neubauer chamber.
Transmission electron microscopy
Briefly, epimastigotes from the Y strain (5610
6 cells/ml) were
treated with the 50% inhibitory concentration (IC50)o f
MDL28170, as previously determined [7] for 72 h in BHI
medium at 28uC. Afterwards, the parasites were fixed with 2.5%
glutaraldehyde in 0.1 M Na-cacodylate buffer (pH 7.2) at room
temperature for 40 min at 25uC and post-fixed with a solution of
1% OsO4, 0.8% potassium ferricyanide and 2.5 mM CaCl2 in the
same buffer for 20 min at 25uC [26]. The cells were dehydrated in
an ascending acetone series and embedded in PolyBed 812 resin.
Ultrathin sections were stained with uranyl acetate and lead citrate
and examined in Jeol JEM1011 transmission electron microscope.
Alternatively, untreated epimastigotes were submitted to pre-
embedding protocol, whereas the parasites were fixed, permeabi-
lized (Triton X-100 0.1%), and incubated with polyclonal rabbit
anti-Dm-calpain (dilution 1:10), followed by labeling with the
secondary anti-rabbit-gold (10 nm) antibody (dilution 1:10) before
the routine protocol described above.
Statistical analysis
All experiments were repeated at least three times, and media or
representative images of these experiments are shown. The data
were analyzed statistically using Student’s t test using EPI-INFO
6.04 (Database and Statistics Program for Public Health) computer
software. P values of 0.05 or less were considered statistically
significant.
Results
The presence of calpain-like molecules in epimastigote forms of
T. cruzi Y strain was accessed by flow cytometry assay and
fluorescence microscopy analyzes using a panel of antibodies
raised against different calpains. The antibodies anti-Dm-Calpain,
anti-CDPIIb, anti-Ha-CalpM and anti-CAP5.5 were capable of
strongly binding to T. cruzi cells, while anti-C21, anti-C23 and
anti-C24 did not recognize epitopes on the parasite cell surface
(Fig. 1A). However, no cross-reactive of the antibodies with
trypomastigote forms were observed. Fluorescence microscopy
(Fig. 1B) and FACS (Fig. 1A) with non-permeabilized parasites are
Figure 1. Detection of cross-reactivity between a calpain-like protein from Trypanosoma cruzi Y strain and anti-calpain antibodies.
(A) Flow cytometric analysis showing the anti-calpain antibodies binding to T. cruzi epimastigote forms. Paraformaldehyde-fixed cells were incubated
in the absence (autofluorescence) or in the presence of 4 anti-calpain antibodies: anti-Dm-calpain, anti-CDPIIb, anti-Ha-CalpM and anti-CAP5.5 (1:100
dilution) and analyzed by flow cytometry. When treated only with the secondary-FITC antibody, cells generated similar curves to that observed in the
autofluorescence of cells (data not shown). Representative data of the analysis of 10000 cells from 1 of 3 experiments are shown. The inset shows the
Western blotting analysis of polypeptides from T. cruzi (lane 1) and D. melanogaster cell extract (lane 2) probed with anti-Dm-calpain antibody. (B)
Fluorescence microscopy showing the labeling of T. cruzi with the anti-Dm-calpain antibody. Fixed cells were analyzed under differential interferential
contrast images (a, c) and immunofluorescence (b, d). Parasites treated only with the secondary antibody presented no fluorescence intensity (b). The
bars represent 1 mm.
doi:10.1371/journal.pone.0018371.g001
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epimastigote forms of T. cruzi. It has been previously shown by our
research group that the anti-Dm-Calpain recognizes a polypeptide
band migrating at approximately 80 kDa in cellular extracts from
the Dm28c strain [7]. Here, we showed that this antibody also
recognized a protein with a similar molecular mass (80 kDa) in
cellular extracts of T. cruzi Y strain (Fig. 1A, inset). For control,
lysates of Drosophila melanogaster were run in parallel, revealing a
reactive band in the same molecular range (Fig. 1A, inset). As
previously reported, the fragment of the D. melanogaster protein
CAA55297.1 that was employed to generate the antibody used in
the present report [21] was compared in a BlastP analysis with T.
cruzi proteins found in GenBank data base. The first 15 hits
(homologues with e-value ranging from 2e-8 to 0.003) all
corresponded to calcium-dependent cysteine peptidases and had
their theoretical molecular mass determined, and 4 out of these 15
homologues presented a molecular mass around 80 kDa: XP_
816697.1 (78.3 kDa), XP_803757.1 (80.8 kDa), XP_820102.1
(82.4 kDa) and XP_816696.1 (82.6 kDa), which supports the
recognition of T. cruzi 80 kDa calpain by the anti-Dm-calpain
antibody [7].
In order to assess a potential function for calpain-like molecules
in T. cruzi, we have performed binding assays with parasites
previously treated with the anti-Dm-calpain antibody, at concen-
trations that did not promote cell agglutination. The blockage of
calpain molecules by the antibody led to a significant reduction in
the capacity of adhesion to the insect guts by T. cruzi in a dose-
dependent manner, the inhibition ranged from 30% to 60% as
antibody concentration rose from 1:250 to 1:50 (Fig. 2A), similar
results were obtained with the other antibodies (data not shown).
On the other hand, parasites treated with the pre-immune serum
at the highest concentration adhered to the guts at a rate similar to
that of the control (Fig. 2A).
Some studies dedicated to clarify the functional mechanisms of
T. cruzi proteins resorted to specific inhibitors as a methodological
alternative [6,7,8,27,28]. In this sense, we performed binding
assays with parasites previously treated with MDL28170, a potent
calpain inhibitor. The compound reduced significantly the
number of parasites adhered to the insect luminal midgut surface
in all drug concentrations tested (6.25–50 mM). At the highest
doses 25 and 50 mM, the adhesion rate was approximately 0.6
epimastigotes per midgut cell while the control was about 1.4
(Fig. 2B), which represents a reduction of 65%. DMSO at a dose
equivalent to the highest concentration used to dissolve the drug
did not promote any significant effect on the parasite adhesion
(Fig. 2B). The effect of anti-calpain antibodies on parasite adhesion
to R. prolixus gut together with FACS and fluorescence analyses
support a surface localization of the calpains. Therefore, we
performed pre-embedding assays with fixed and permeabilized
parasites incubated with anti-Dm-Calpain at 4uC, afterwards
parasites were routinely fixed and the ultrathin sections analyzed
by transmission electron microscopy. The results showed labeling
mainly at T. cruzi cytoplasm (Fig. 3), but scarce labeling in few
fields was also detected at the parasite membrane (Figure S1). The
parasites incubated with rabbit pre-immune serum (control)
showed no labeling (Fig. 3A).
These results led us to investigate whether MDL28170 might
have any effect on the metacyclogenesis process. For this purpose,
we performed experiments in which late-log phase epimastigotes
form the Dm28c clone were submitted to the differentiation assay,
and treated or not for 4 days with MDL28170 at concentrations
ranging from 6.25 to 50 mM. The Dm28c was selected instead of
Y strain because this strain did not yield a satisfactory rate of
differentiation to metacyclic trypomastigotes. Under this experi-
mental condition the parasites maintained their viability, as judged
by their morphology and flagellar motility in which the density of
live parasites was approximately the same as the control. It should
also be pointed out that MDL28170 has a trypanostatic effect on
T. cruzi, since cells pre-treated for 72 h with the calpain inhibitor
even at 70 mM resumed growth when subcultured in a drug-free
fresh medium [7]. Finally, the metacyclogenesis assay revealed
Figure 2. Effect of MDL28170 and anti-calpain antibody in the
interaction process between T. cruzi and explanted guts of
Rhodnius prolixus. (A) Epimastigotes (1.0610
7 cells) were treated for
1 h at 28uC with the anti-Dm-calpain (1:50, 1:100 and 1:250) or the pre-
immune serum (1:50). (B) Epimastigotes (1.0610
7 cells) were treated for
30 min at 28uC with increasing concentrations of MDL28170 (6.25 to
50 mM) in 200 ml of BHI. The data from DMSO represents the
concentration present in the highest dose of the drug. The viability
of the parasites was not affected by the treatments used in this set of
experiments. Then, parasites were washed, and incubated for 20 min at
28uC with R. prolixus dissected posterior midguts that were sliced open
longitudinally. Subsequently, the explanted midguts were spread onto
glass slides to count the number of attached parasites per epithelial
cells. For each experimental group 4 insect midguts were used, and 100
epithelial cells were counted randomly. The results are shown as the
mean 6 standard error of the mean of three independent experiments.
Symbols denote systems treated with MDL28170 or anti-calpain
antibody that had a adhesion rate significantly different from the
control (P,0.05 or P,0.001; Student’s t test).
doi:10.1371/journal.pone.0018371.g002
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since in cultures without MDL28170 the number of metacyclic
trypomastigotes increased over time, whereas MDL28170 treat-
ment inhibited the differentiation process almost to 50% in the
highest drug concentration. DMSO at a dose equivalent to the
highest concentration used to dissolve the drug did not interfere in
the metacyclogenesis (Fig. 4). Then, we decided to investigate
whether anti-calpain antibodies would prevent metacyclogenesis,
all antibodies tested even at the highest concentration (1:50) did
not promote a significant effect on parasite differentiation (data not
shown).
Finally, we decided to evaluate the direct effect of the
MDL28170 on bloodstream trypomastigotes viability in vitro after
24 h of treatment at 37uC. The inhibitor at 25 mM powerfully
reduced parasite viability at about 63% in comparison to control
(Fig. 5). Bloodstream trypomastigotes cultured in the presence of
DMSO at a dose used to dissolve the highest drug concentration
presented no significant effect (Fig. 5).
Given that the calpain inhibitor can reduce the growth of
epimastigote forms with a trypanostatic effect [7], interfere in the
parasite adhesion to the insect midgut and in the differentiation
process of epimastigotes into metacyclic trypomastigotes, we
decided to investigate the ultrastructural effects of MDL28170
against the epimastigote forms, by transmission electron micros-
copy. For this purpose, the morphology of non-treated cells
Figure 3. Ultrastructural immunolabelling of calpains in T. cruzi
epimastigotes. (A) Secondary antibody control presenting no gold
particles. (B,C) Parasites showing anti-calpain immunolabelling in the
cytosol (arrows). Indetail, itwas observed in 10 nm-gold particles. Bars =
200 nm. Inset bars = 100 nm.
doi:10.1371/journal.pone.0018371.g003
Figure 4. Effect of MDL28170 on T. cruzi metacyclogenesis in
vitro. Epimastigotes from the stationary phase of growth (5.0610
8 cells)
were incubated in TAU3AAG medium for 96 h to induce cellular
differentiation to metacyclic trypomastigotes. Parasites were treated
with increasing concentrations of MDL28170 (6.25 to 50 mM). The data
from DMSO represents the concentration present in the highest dose of
the drug. At each time point, culture supernatants were collected and
the number of epimastigotes and metacyclic trypomastigotes was
determined by cell counting in a Neubauer chamber. The results
correspond to the mean of three independent experiments performed
in triplicate. Symbols denote systems treated with MDL28170 that had a
percentage of metacyclic trypomastigotes significantly different from
the control (P,0.05 or P,0,001, Student’s t test).
doi:10.1371/journal.pone.0018371.g004
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treated for 72 h with 34 mM of MDL28170, the 50% inhibitory
concentration (IC50) of MDL28170, as previously determined [7]
(Fig. 6c–g). Results showed an important injury to the reservo-
somes (Fig. 6c–e), plasma membrane (Fig. 6d,g) and Golgi
(Fig. 6f,g). Reservosomes and Golgi were severely affected,
showing a washed-out appearance with loss of organelles’
electrondensity and complete disruption of their membranes.
Discussion
Over the past few years some studies have described the
presence of calpain-related proteins in trypanosomatids. At first, a
classical study employing whole genome analyses showed the
presence of a large and diverse family of calpains in T. brucei, L.
major and T. cruzi [14]. In this sense, our group became involved in
the study of these molecules though the report of the expression of
calpain-like molecules and the effects of the calpain inhibitor
MDL28170 against the etiological agents of Chagas’ disease and
leishmaniasis [6,7,8]. In the present study, we demonstrated that
MDL28170 also inhibited T. cruzi adhesion to the insect gut,
arrested the metacyclogenesis process, reduced the bloodstream
trypomastigote viability and promoted significant ultrastructural
effects on reservosomes and Golgi of epimastigote forms. In
addition, it was shown that anti-calpain antibodies impair parasite
adhesion to the midgut surface of R. prolixus in vitro.
The calpain inhibitor MDL28170 impaired significantly the
adhesion rate of epimastigotes to the midgut of R. prolixus in vitro
suggesting that calpain-like molecules could play an important role
in this part of the parasite life cycle. Although MDL28170 is
relatively a specific calpain inhibitor, it cannot be ruled out that it
may act on other T. cruzi cysteine peptidases to a lesser level [29].
Several classes of inhibitors, including peptidyl epoxide, aldehyde,
and ketoamide inhibitors, targeting the active site have proven
effective against calpains and are in the process of evaluation in
animal models to treat human disease. However, a major
limitation of such inhibitors is their lack of specificity. The
development of a new class of calpain inhibitors that interact with
domains outside of the catalytic site of calpain may provide greater
specificity, which may allow to more precisely assess its function
[30]. Indeed, this approach would be particularly interesting for
calpain kinetoplastids since it is speculated that most calpain-like
proteins do not have proteolytic activity, since the amino acid
residues essential for catalytic activity are altered [14]. It has been
speculated that calpains devoid of activity are involved in
regulatory processes [14,31], for instance, calpain-6 is involved
in microtubules stabilization through a non-catalytic mechanism
[32]. Up to date, a calpain with proteolytic activity in
trypanosomatids was only described in C. deanei, an insect
trypanosomatid. However, since its microsequencing was not
performed; it is still an open question. Also, since C. deanei genome
is not available it is not possible to search for calpain sequences
with the conserved catalytic triad [16]. It is interesting to note that
with few exceptions, most organisms outside the animal kingdom
have only a single calpain gene, while in the Trypanosomatidae
family, there is a surprising expansion of genes, which may reflect
parasite plasticity to face distinct environments, such as the
mammalian host and the insect vector [14,33]. Therefore,
although the results employing MDL28170 must be interpreted
with caution, the anti-calpain antibodies were capable of
significantly reducing the number of bound parasites to the
luminal midgut surface of the insect host, which supports the
possible involvement of calpains.
A first pre-requisite for calpain-like molecules to act on parasite
binding to the insect midgut would be its surface location.
Typically, calpains are cytosolic enzymes. Although membrane
binding is not well substantiated for classical calpains, predicted
transmembrane segments in phytocalpain and some ciliate
calpains suggest an evolutionary link between calpain function
and membranes [34]. At least two acylated calpain-like proteins in
the kinetoplastids L. major and T. brucei are biochemically
associated or co-localize with cellular membranes [35,15].
Acylated proteins are often associated with the cytoplasmic face
of membranes and lipid rafts, where they are implicated in signal
transduction [35,15]. Reversible externalization of intracellular
proteins following reparable mechanical damage of the plasma
membrane has been recently reported for cells in tissues of
multicellular organisms [36]. Calpains have been described in the
surface of the tegument of male adult worms, being secreted by
cercarian penetration glands [37]. Whether calpains are transient-
ly or constantly present at T. cruzi surface remains to be elucidated.
Bioinformatics analysis gives indication of putative acylation,
myristoylation and palmitoylation motifs in T. cruzi calpains,
suggesting that they may be membrane-associated [38] (Ennes-
Vidal, unpublished data). Accordingly, TcCALPx11 (XP_
816697.1) partitioned in the insoluble fraction after detergent
extraction, suggesting an association with membranes [39].
Additionally, calpains were identified in a proteomic analysis of
detergent-solubilized membrane proteins from T. cruzi [38]. FACS
analysis revealed a clear predomination of calpains in T. cruzi
cytosol, since detergent permeabilization increased the fluores-
cence intensity [7]. The immunofluorescence analysis with non-
permeabilized parasites is suggestive of calpain surface localiza-
tion, and the effect of anti-Dm-calpain on parasite binding to the
Figure 5. In vitro efficacy of MDL28170 on T. cruzi bloodstream
trypomastigotes viability. Bloodstream trypomastigote forms ob-
tained from Swiss mice (5.0610
6 cells) were treated with increasing
concentrations of MDL28170 (6.25 to 50 mM) for 24 h. The data from
DMSO represents the concentration present in the highest dose of the
drug. Thereafter, viable parasites were counted by trypan blue
exclusion and mobility. The results are expressed in viability percentage
in relation to control. The results correspond to the mean of three
independent experiments performed in triplicate. Symbols denote
systems treated with MDL28170 that had a viability percentage
significantly different from the control (P,0.05 or P,0.001; Student’s
t test).
doi:10.1371/journal.pone.0018371.g005
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embedding technique did not reveal significant membrane
labeling. Calpains localization in T. cruzi is still an open issue,
and the main goal of our laboratory is to help to elucidate this
question. One possible explanation would be that some isoforms,
recognized by the same antibody, are abundantly expressed in the
cytosol and recruits more efficiently the antibody. Indeed, some
membrane labeling was detected, in scarce fields.
The metacyclogenesis process consists in the differentiation of
non-infectious T. cruzi epimastigotes into pathogenic metacyclic
trypomastigotes. During this process, epimastigotes adhere to the
epithelium of the insect midgut before transforming into
metacyclic trypomastigotes [2]. The adhesion is thought to be a
pre-requisite for differentiation to the infective form, but less is
known about how epimastigote adhesion triggers the differentia-
tion process after the nutritional stress [40]. Our findings from T.
cruzi in vitro metacyclogenesis showed that the calpain inhibitor
impaired the differentiation process, which is not surprising since
previous studies have shown that cysteine peptidases are required
during the metacyclogenesis process [41,42]. Once again, it should
be taken into account that MDL28170 might be acting on other T.
cruzi cysteine peptidases. In addition, this approach was performed
with Dm28c instead of the Y strain. Distinct levels of expression of
calpains were detected between Y strain and Dm28c: higher levels
Figure 6. Ultrastructural effects of MDL28170 in T. cruzi epimastigotes. (a,b) Control parasites showing typical elongated morphology with
normal kinetoplast (K), mitochondrion (M), nucleus (N) and Golgi (G). (c–g) The treatment of epimastigotes with 34 mM of the inhibitor for 72 h led to
an extensive disorganization in the reservosomes (asterisks), plasma membrane alterations (arrows) as well as to the disruption of Golgi cisternae
(stars). Bars = 0.5 mm.
doi:10.1371/journal.pone.0018371.g006
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[7]. Therefore the better performance of the Dm28c to
differentiate in vitro does not have a direct correlation with calpain
expression, at least for the isoforms detected by the anti-Dm-
calpain. When live parasites were allowed to differentiate in the
presence of the antibody, no significant effect was observed. Since
we are dealing with live parasites and the incubation time required
for differentiation is too long, the live parasites could be removing
the proteins from the surface, since antibodies can be quickly
interiorized by endocytosis and degraded [42,43], or even,
subjected to constant secretion to the surface such that bound
calpains are sloughed off and replaced. Although our data do not
allow to infer if calpain-like molecules are actually involved in T.
cruzi metacyclogeneis, the transcriptome of several T. cruzi
indicated that TcCALPx11 is up-regulated in epimastigotes under
nutritional stress [39], a requirement for differentiation to
metacyclic trypomastigotes [4].
Finally, the ultrastructural data demonstrated severe effects of
MDL28170 in the reservosomes and Golgi, which showed a
washed-out appearance with loss of organelles electrondensity and
complete disruption of their membranes. These results indicate
that the calpain inhibitor strongly affect T. cruzi epimastigote
forms. Proteins and lipids accumulated in reservosomes of
epimastigote forms are used as an energy source during
metacyclogenesis, resulting in the disappearance of these organ-
elles in the vertebrate stages of the parasite [44]. Besides protein
degradation during metacyclogenesis, differentiating parasites
must quickly synthesize new trypomastigote-specific proteins.
Therefore, the effects promoted by MDL28170 in crucial
organelles for protein degradation and synthesis are in accordance
to metacyclogenesis inhibition. Cruzipain has been implicated as
the main peptidase involved in protein degradation in reservo-
somes [44,45]. Similar ultrastructural alterations were observed in
epimastigotes treated with inhibitors from the major cysteine
peptidase of T. cruzi, the cruzipain [46]. The cysteine peptidase
inhibitor was capable of modifying the intracellular localization of
cruzipain and induced its accumulation in peripheral dilations of
Golgi cistern, these abnormalities were followed by distention of
endoplasmatic reticulum and nuclear membranes [46]. It should
be taken into account that MDL28170 could act nonspecifically
on cruzipain. Nevertheless, a recent proteomic analysis showed the
presence of calpain-like molecules in a purified fraction of
reservosomes [45].
It has been almost ten years since the first calpain-like protein
CAP5.5 was characterized in T. brucei [15]. The distribution of
calpains in the ditinct life stage of T. cruzi is still unkown. Here, we
showed that the anti-calpain antibody reacts with epimastigotes,
but not bloodstream trypomastigotes, while amastiogtes were not
assessed. In 2008, Giese and collaborators [39] also reported an
epimastigote-specific calpain, which is one of the calpains
recognized by the antibody used in the present work. Since
calpains are a multigenic family, it cannot be ascertained if all
calpains are indeed epimastigote-specific. Nevertheless, at least the
four proteins recognized by the anti-Dm-calpain are epimastigote-
specific, which could suggest a role in the adaptation of this life
stage to the insect vector environment, as previously suggested
[39]. Corroborating this view, we are demonstrating a probable
involvement of calpains in insect midgut attachment, and
metacyclogenesis. However, it should be reinforced that at least
these four proteins have the catalytic triad altered and it is unlikely
that they restrained catalytic properties. Therefore, our main goals
now are a carefull analysis of calpain expression in the distinct life
forms, which will help to shed some light on calpain functions.
Supporting Information
Figure S1 Ultrastructural immunolabelling of calpain
in T. cruzi epimastigotes surface. (A) The parasite presented
cytosolic labeling and scarce gold-particles in the plasma and
flagellar membranes (squares). (B,C) The high magnification of
plasma membrane and the flagellar pocket regions evidenced the
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